Header cover image

Household Healthcare Sector

Results

2301

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2301 companies

Orthocell

Market Cap: AU$296.4m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.

OCC

AU$1.23

7D

-0.4%

1Y

226.7%

CARGO Therapeutics

Market Cap: US$190.4m

A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

CRGX

US$4.22

7D

2.9%

1Y

-77.4%

scPharmaceuticals

Market Cap: US$189.0m

A pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care.

SCPH

US$3.55

7D

1.3%

1Y

-11.5%

Eledon Pharmaceuticals

Market Cap: US$188.6m

Operates as a clinical stage biotechnology company.

ELDN

US$3.09

7D

2.3%

1Y

19.8%

Kodiak Sciences

Market Cap: US$188.4m

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

KOD

US$3.50

7D

-1.0%

1Y

18.6%

Pacific Smiles Group

Market Cap: AU$291.7m

Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.

PSQ

AU$1.81

7D

1.4%

1Y

-4.7%

Inhibrx Biosciences

Market Cap: US$186.9m

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

INBX

US$13.75

7D

9.6%

1Y

-13.3%

Kindly MD

Market Cap: US$186.7m

A healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services.

NAKA

US$24.23

7D

6.1%

1Y

n/a

Sight Sciences

Market Cap: US$186.6m

An ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases.

SGHT

US$3.52

7D

7.3%

1Y

-46.0%

Omeros

Market Cap: US$185.7m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

OMER

US$3.14

7D

1.0%

1Y

-4.8%

Avacta Group

Market Cap: UK£136.5m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

AVCT

UK£0.38

7D

32.7%

1Y

-12.8%

High Tide

Market Cap: CA$254.1m

Engages in the cannabis retail business in Canada, the United States, and internationally.

HITI

CA$3.09

7D

-2.5%

1Y

-3.4%

Panamera Holdings

Market Cap: US$182.0m

Does not have significant operations.

PHCI

US$4.49

7D

12.3%

1Y

349.0%

Journey Medical

Market Cap: US$181.8m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

DERM

US$8.07

7D

18.3%

1Y

112.4%

Organigram Global

Market Cap: CA$250.4m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

OGI

CA$1.87

7D

-1.1%

1Y

-20.4%

UroGen Pharma

Market Cap: US$181.2m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

URGN

US$4.05

7D

-2.9%

1Y

-69.5%

Deltex Medical Group

Market Cap: US$180.6m

Manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, and internationally.

DTXM.F

US$0.095

7D

0%

1Y

n/a

Stereotaxis

Market Cap: US$180.6m

Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

STXS

US$2.12

7D

5.0%

1Y

5.5%

TriSalus Life Sciences

Market Cap: US$180.4m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.

TLSI

US$5.57

7D

2.4%

1Y

-25.7%

ProQR Therapeutics

Market Cap: US$179.1m

A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

PRQR

US$1.74

7D

3.0%

1Y

-4.9%

DiaMedica Therapeutics

Market Cap: US$178.4m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

DMAC

US$4.19

7D

3.5%

1Y

51.3%

Spectral Medical

Market Cap: CA$245.2m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

EDT

CA$0.85

7D

2.4%

1Y

80.9%

CVRx

Market Cap: US$176.0m

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.

CVRX

US$6.80

7D

2.3%

1Y

-1.2%

AFT Pharmaceuticals

Market Cap: NZ$294.7m

Engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

AFT

NZ$2.81

7D

4.1%

1Y

-7.0%

Inogen

Market Cap: US$175.6m

A medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.

INGN

US$6.53

7D

-3.3%

1Y

-19.5%

Utah Medical Products

Market Cap: US$175.6m

Provides medical devices for the healthcare industry worldwide.

UTMD

US$54.58

7D

1.7%

1Y

-18.7%

Instil Bio

Market Cap: US$175.5m

A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.

TIL

US$30.35

7D

23.3%

1Y

174.9%

INmune Bio

Market Cap: US$170.8m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

INMB

US$7.36

7D

-1.9%

1Y

-22.8%

Electromed

Market Cap: US$170.5m

Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

ELMD

US$20.41

7D

0.3%

1Y

38.0%

Cybin

Market Cap: US$170.4m

A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

CYBN

US$8.06

7D

11.0%

1Y

-39.3%

Puma Biotechnology

Market Cap: US$167.3m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

PBYI

US$3.38

7D

4.0%

1Y

-11.3%

AC Immune

Market Cap: US$167.2m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

ACIU

US$1.68

7D

1.8%

1Y

-54.2%

Lucid Diagnostics

Market Cap: US$164.4m

Operates as a commercial-stage medical diagnostics technology company in the United States.

LUCD

US$1.52

7D

14.3%

1Y

67.6%

AVITA Medical

Market Cap: US$164.2m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

RCEL

US$5.77

7D

-9.8%

1Y

-38.0%

Accuray

Market Cap: US$163.8m

Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

ARAY

US$1.58

7D

0%

1Y

0.6%

Procaps Group

Market Cap: US$163.6m

Develops, produces, and markets pharmaceutical solutions worldwide.

PROC.F

US$0.01

7D

-99.3%

1Y

-99.6%

Page 18 of 64